Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First US Branded Ophthalmic Launch A ‘Milestone’ For Sun

Executive Summary

India’s biggest drug firm Sun has just launched its first branded ophthalmic product in the US, marking what the company calls “a milestone” in its quest to build scale and seek steady revenue streams in the global specialty drug business.

Advertisement

Related Content

Sun Plunges To Quarterly Loss, Outlook Challenging
Pfizer Ex-Marketing Director Agrees To Injunction, Ending Trade Secret Suit
Tepid Q3 For Sun But Momentum In Specialty Build-Up
Sun Acquires Novartis Cancer Drug In Specialty Push

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC097790

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel